The pathways related to neurodegenerative disease, such as Alzheimer’s disease and Huntington’s disease, were also enriched with two essential DEPs (GAPDH, PLCB3 and SP1, PLCB3, respectively). This evidence concerns the gene SP1 and neurodegenerative disease.